Farletuzumab ecteribulin, CAS [[2407465-18-1]]

Produktübersicht

• Artikelname: Farletuzumab ecteribulin, CAS [[2407465-18-1]]
• Artikelnummer: TGM-T77908
• Hersteller Artikelnummer: T77908
• Alternativnummer: TGM-T77908-1MG,TGM-T77908-5MG,TGM-T77908-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MORAb-202

Produktbeschreibung

Farletuzumab ecteribulin (MORAb-202) is a highly cytotoxic antibody-drug conjugate (ADC) targeting human folate receptor alpha (FRA). This ADC comprises the humanized Farletuzumab antibody linked to Mal-PEG2-Val-Cit-PAB-eribulin through reduced interchain disulfide bonds, with an agent-to-antibody ratio of 4.0, demonstrating potent antitumor activity against FRA-positive cells in vitro.

Produkteigenschaften

• CAS Nummer: [2407465-18-1]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)